Skip to main content
Top

Breast Cancer Research and Treatment

Issue 2/2006

Content (14 Articles)

Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha

Hye-Sook Seo, David G. DeNardo, Yves Jacquot, Ioanna Laïos, Doris Salazar Vidal, Carmen Rojas Zambrana, Guy Leclercq, Powel H. Brown

Preclinical study

Hypoxia inducible factor-1α correlates with VEGF-C expression and lymphangiogenesis in breast cancer

Sebastian F. Schoppmann, Alexandra Fenzl, Monika Schindl, Thomas Bachleitner-Hofmann, Katalin Nagy, Michael Gnant, Reinhard Horvat, Raimund Jakesz, Peter Birner

Preclinical study

A role for atm in E-cadherin-mediated contact inhibition in epithelial cells

Geneviève Vaudan Vutskits, Patrick Salmon, Laurence Mayor, Laszlo Vutskits, Christophe Cudré-Mauroux, Jesus Soriano, Roberto Montesano, Philippe Maillet, André-Pascal Sappino

Preclinical study

LHRH-conjugated Magnetic Iron Oxide Nanoparticles for Detection of Breast Cancer Metastases

Carola Leuschner, Challa SSR Kumar, William Hansel, Wole Soboyejo, Jikou Zhou, Josef Hormes

Preclinical investigation

A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer

Cari J. McDonald, Charles Erlichman, James N. Ingle, Gabriela A. Rosales, Cory Allen, Suzanne M. Greiner, Mary E. Harvey, Paula J. Zollman, Stephen J. Russell, Evanthia Galanis

Preclinical study

Prognostic impact of Skp2 and p27 in human breast cancer

Frank Traub, Michael Mengel, Hans J. Lück, Hans H. Kreipe, Reinhard von Wasielewski

Preclinical study

Telomere content correlates with stage and prognosis in breast cancer

Colleen A. Fordyce, Christopher M. Heaphy, Marco Bisoffi, Jessica L. Wyaco, Nancy E. Joste, Aroop Mangalik, Kathy B. Baumgartner, Richard N. Baumgartner, William C. Hunt, Jeffrey K. Griffith

Epidemiology

Adherence to tamoxifen over the five-year course

Timothy L. Lash, Matthew P. Fox, Jennifer L. Westrup, Aliza K. Fink, Rebecca A. Silliman

Epidemiology

Incidence and risk factors associated with bilateral breast cancer in area with early age diagnosis but low incidence of primary breast cancer: analysis of 10-year longitudinal cohort in Taiwan

Wen-Hung Kuo, Amy Ming-Fang Yen, Po-Huang Lee, Ming-Feng Hou, Shin-Cheh Chen, Kai-Mo Chen, Tony Hsiu-Hsi Chen, King-Jen Chang

Epidemiology

Flame-broiled food, NAT2acetylator phenotype, and breast cancer risk among women with benign breast disease

Lisa Gallicchio, Meghan A. McSorley, Craig J. Newschaffer, Lucy W. Thuita, Pedram Argani, Sandra C. Hoffman, Kathy J. Helzlsouer

Epidemiology

Catechol-O-methyltransferase haplotypes and breast cancer among women on Long Island, New York

Mia M. Gaudet, Jeannette T. Bensen, Jane Schroeder, Andrew F. Olshan, Mary Beth Terry, Sybil M. Eng, Susan L. Teitelbaum, Julie A. Britton, Teresa A. Lehman, Alfred I. Neugut, Christine B. Ambrosone, Regina M. Santella, Marilie D. Gammon

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine